Chief Medical/Scientific Officers Conference


Sharing Patient-Centered Outcomes Data: Building A Better Mousetrap Based on Learnings from the Research Community is the theme for the 2018 NHC Chief Medical/Scientific Officers Conference, October 15-16 at the Capital Hilton in Washington, DC.

We work in a landscape of rapidly evolving data and technology. Patient-focused medical-product development means collecting, warehousing, analyzing, and sharing patient-centered outcomes data in a way that is meaningful and useful - for everyone. At this conference you will learn current, cutting-edge approaches to build systems for the future. Featuring key thought leaders, industry experts, and policy makers, this is a must-attend event for all research staff from NHC's diverse membership - and beyond. Check out the agenda and register for the meeting.

Conference pricing:

  • Complimentary registration for patient group, nonprofit organization, and government staff. For non-member registration, please contact Meagan Brodsky ( for your admission code. 
  • Industry members receive complimentary registration for the Chief Medical or Chief Scientific Officer. $699 per person for other staff.
  • Nonmember industry staff may attend for $699 per person.

Sponsorship opportunities are available. Contact NHC Senior Director of Member Services and Development Kelly Garrity at or 202-973-0541.

See highlights from the 2017 Chief Medical/Scientific Officers Conference.

Chief medical, scientific officers, and research directors traditionally work within their respective disease groups or industries. Each year the CM/SO Conference brings together research leaders from patient groups, nonprofit health organizations, and industry, offering participants a rare opportunity to connect, communicate, and network. Multi-stakeholder research leaders are able to share with a broader scientific audience their experiences, accomplishments, best practices, and resulting impact on science and medicine. Attendees learn how a variety of stakeholders, including patient organizations, pharmaceutical companies, and others, are enhancing patient access to effective treatments to improve patient outcomes.